Integrated Wealth Concepts’s VanEck Biotech ETF BBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$203K Buy
+1,082
New +$208K ﹤0.01% 2103
2025
Q1
Sell
-1,650
Closed -$259K 1750
2024
Q4
$259K Buy
1,650
+2
+0.1% +$336 ﹤0.01% 1453
2024
Q3
$292K Hold
1,648
﹤0.01% 1359
2024
Q2
$278K Sell
1,648
-6
-0.4% -$981 ﹤0.01% 1354
2024
Q1
$275K Sell
1,654
-48
-3% -$7.95K ﹤0.01% 1368
2023
Q4
$281K Sell
1,702
-1
-0.1% -$154 ﹤0.01% 1298
2023
Q3
$265K Hold
1,703
﹤0.01% 1288
2023
Q2
$266K Sell
1,703
-3
-0.2% -$479 ﹤0.01% 1291
2023
Q1
$277K Buy
1,706
+409
+32% +$66.2K 0.01% 1090
2022
Q4
$207K Sell
1,297
-234
-15% -$37.1K 0.01% 935
2022
Q3
$216K Hold
1,531
0.01% 839
2022
Q2
$223K Hold
1,531
0.01% 859
2022
Q1
$248K Hold
1,531
0.01% 806
2021
Q4
$290K Sell
1,531
-224
-13% -$43.2K 0.01% 789
2021
Q3
$355K Buy
1,755
+119
+7% +$25K 0.01% 674
2021
Q2
$330K Hold
1,636
0.01% 632
2021
Q1
$287K Buy
1,636
+26
+2% +$4.7K 0.01% 599
2020
Q4
$273K Buy
1,610
+3
+0.2% +$494 0.01% 534
2020
Q3
$260K Buy
+1,607
New +$261K 0.02% 484
2019
Q3
Sell
-1,617
Closed -$208K 425
2019
Q2
$208K Buy
+1,617
New +$199K 0.03% 356

Other funds holding BBH

Integrated Wealth Concepts's BBH Position: Q1 2026 in Review

Integrated Wealth Concepts opened a new position in VanEck Biotech ETF (BBH) in Q1 2026: 1,082 shares worth $203K. The stake represents ﹤0.01% of the portfolio and ranks #2103 among its holdings. This is a return to the name: Integrated Wealth Concepts previously reported a position in BBH as recently as Q4 2024.

Integrated Wealth Concepts first reported a position in BBH in Q2 2019 and has held it in 20 quarters since. The position peaked at $355K in Q3 2021. 112 funds tracked by Wall St. Rank hold BBH as of Q1 2026.

  • Integrated Wealth Concepts held 1,082 shares of VanEck Biotech ETF worth $203K as of Q1 2026.
  • VanEck Biotech ETF was a new Integrated Wealth Concepts position in Q1 2026.
  • VanEck Biotech ETF made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #2103 holding.
  • Integrated Wealth Concepts first reported a position in VanEck Biotech ETF in Q2 2019 and has held it in 20 quarters since.
  • Integrated Wealth Concepts's VanEck Biotech ETF position peaked at $355K in Q3 2021.
  • 112 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.